18 February / March 2021
Collaboration to Set International Standard for Botanical Extracts Processing Announced
Global Allied Processing Solutions (G-APS) has announced its strategic focus on the global organic material industry through its recent formation of an alliance representing companies on the forefront of technological advancements in processing equipment and practices. Founding members RotaChrom Technologies, the developer of the world’s first industrial- scale Centrifugal Partition Chromatography (CPC) technology platform, and Heidolph Instruments, the leader in the production of premium laboratory equipment, created G-APS to further establish best practices for the processing of raw materials through education and innovative equipment offerings.
RotaChrom and Heidolph formed G-APS through a shared vision and understanding of the global processing marketplace spanning several industries including pharmaceuticals, natural extracts, food and beverages, and cosmetics and fragrances. The organisation’s
goal is to provide businesses with one-stop-shop access to multiple solutions for their processing and manufacturing infrastructure needs, with a specific focus on the extraction and purification of botanically-derived compounds and molecules.
Founding companies RotaChrom and Heidolph are high-end equipment producers in the respective fields of purification and solvent recovery. The combination of the two founding members’ technologies resulted in a highly efficient system based on an optimised collaborative working principle that G-APS will expand upon with the addition of other member companies. To showcase the synergies between the companies’ equipment, the organisation in installing showrooms in multiple locations in Europe and North America. G-APS will announce more information when the installations are ready for public access.
G-APS aims to set standards for the processing industry as well as bring strategic cooperation, shared research and development, integrated project and sales activities, and value-add metrics needed for forward-thinking innovation. In addition to efficiency, the alliance is committed to bringing together systems that are flexible against the ever-changing regulatory and product landscape of the pharmaceutical, natural extract, food and beverage, and cosmetic and fragrance industries.
More information online:
ilmt.co/PL/Ao4q
Strategic Partnership to Accelerate Biotherapeutic Characterisation Workflows Announced
Protein Metrics and MOBILion Systems Inc have announced their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that work exclusively with MOBILion’s High- Resolution Ion Mobility (HRIM) Mass Spectrometry (MS) System. Combining best in class data analysis with the fastest, highest resolution analysis of multiple Critical Quality Attributes (CQA) to accelerate biotherapeutic drug development and enhance characterisation capabilities that affect product quality, safety, and efficacy.
MOBILion’s HRIM product addresses deficiencies in current biopharmaceutical characterisation workflows that rely on Liquid Chromatography Mass Spectrometry (LC-MS). This best-in-class separations technology enables rapid and reproducible molecular and structural characterisation of biotherapeutics with two-minute, high-resolution released glycan analysis and five-minute peptide mapping while providing more complete monitoring of Post Translational Modifications (PTMs).
Protein Metrics’ Byos Platform enables researchers to move from raw data files to report in just minutes, with the click of a mouse. Designed to manage the burgeoning volume and complexity of analytical data, the platform has established itself as an analytical workhorse for protein characterisation in biopharmaceutical laboratories.
The union of both platforms delivers on the promise of eliminating impediments to identifying and characterising CQAs with the reliability, repeatability and speed required in modern biopharmaceutical organisations developing more complex protein therapeutics.
“Combining the fastest, highest resolution, most reproducible therapeutic protein analysis with simple, automated data analysis and visualisation provides our mutual pharmaceutical customers with a streamlined workflow that will help bring safer, more efficacious drugs to market faster,” said Melissa Sherman, CEO of MOBILion Systems. “The push button, software driven approach of both the sample analysis and data analysis deliver the speed and efficiency our customers seek.”
“The whole is clearly greater than the sum of parts,” remarked Kevin Cronin, Vice President Corporate Development at Protein Metrics. “With over 100 companies worldwide trusting our protein analysis workflows and an industry recognised gold standard in glycan analysis, this partnership enables our client base to rapidly integrate cutting edge platforms with confidence and ease.”
More information online:
ilmt.co/PL/oDKB and
ilmt.co/PL/Ypm1
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
